CoChat

The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.

Thiazolidinediones

Yki-Järvinen, Hannele · 2004 · New England Journal of Medicine

Abstract

Despite a large need for new hypoglycemic therapies, given the epidemic of type 2 diabetes, very few agents have been introduced during the past 20 years. The thiazolidinediones represent a potentially important new group of drugs with a mechanism of action differing from and perhaps complementary to that of existing therapies. This article discusses present data on mechanisms, indications, and limitations of thiazolidinedione therapy.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmra041001

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 110 references

Research works printed but not linked: 3

  1. Yki-Järvinen H. Insulin resistance in type 2 diabetes. In: Pickup JC, Williams G, eds. Textbook of diabetes. 3rd ed. Oxford, England: Blackwell, 2003:22.1-22.19.
  2. 10.1111/j.1572-0241.2003.07486.x · doi:10.1111/j.1572-0241.2003.07486.x · Paper page
  3. Charbonnel B, 2002, Diabetologia, 45, A107

Cited by

See all 1,830

Metadata

Authors
Yki-Järvinen, H.
Venue
New England Journal of Medicine
Published
2004-09-09
Volume
351
Issue
11
Pages
1106-1118
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4240449862
Cited by
1,830
References
110
Citations by year
2026: 26 · 2025: 33 · 2024: 41 · 2023: 45 · 2022: 57 · 2021: 60 · 2020: 55 · 2019: 53 · 2018: 74 · 2017: 74 · 2016: 65 · 2015: 76 · 2014: 75 · 2013: 94 · 2012: 108
FWCI
19.93
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
thiazolidinediones, type 2 diabetes, hypoglycemic therapy, mechanism of action, antidiabetic drugs, drug indications, drug limitations
MeSH terms
Adipose Tissue, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fatty Liver, Female, Gene Expression Regulation, Humans, Hypoglycemic Agents, Insulin Resistance, Lipodystrophy, Polycystic Ovary Syndrome, Risk Factors, Transcription Factors, Biomarkers, Receptors, Cytoplasmic and Nuclear, Thiazolidinediones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thiazolidinediones. https://app.cochat.ai/papers/10.1056/nejmra041001
The paper
Yki-Järvinen, H. (2004). Thiazolidinediones. New England Journal of Medicine. https://doi.org/10.1056/nejmra041001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.